{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:06:05Z","timestamp":1780682765651,"version":"3.54.1"},"posted":{"date-parts":[[2026,6,3]]},"group-title":"Neuroscience","reference-count":53,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"NIH\/NINDS","award":["RO1-NS118145"],"award-info":[{"award-number":["RO1-NS118145"]}]},{"name":"NIH\/NIGMS","award":["R35 GM118112"],"award-info":[{"award-number":["R35 GM118112"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Dysregulated peptidyl deiminase 2 (PAD2) and aberrant protein citrullination (PC), a posttranslational modification (PTM), are involved in various inflammatory and neurodegenerative diseases. We previously showed in transgenic mice and postmortem human tissues that PC and PAD2 are altered in amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by motor neurons loss, paralysis, and death. Herein, we investigated the role of PAD2 in ALS by PAD2 knockout in a SOD1-ALS mouse model.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    To investigate the role of PAD2-induced citrullination in ALS pathogenesis, we generated PAD2 knockout (PAD2KO) in SOD1\n                    <jats:sup>G93A<\/jats:sup>\n                    ALS mouse model and investigated the consequent modulation on the neuropathology and clinical symptoms, using molecular biology techniques such as qPCR, Western blotting, confocal microscopy, and electron microscopy. Additionally, we identified C3 as being citrullinated in human ALS using ionFinder.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our results show that PAD2KO blocked the increased PC and reduced myelin basic protein (MBP) aggregates in the ALS model. PAD2KO also improved motor neuron survival and the integrity of myelin, axons, and neuromuscular junctions, and reduced microgliosis in the white matter and C3 protein levels in astrocytes. Clinically, data from monitoring the body weight changes suggests that PAD2KO modulates the course of the disease in the ALS mouse model, accelerating the onset while slowing the progression after the onset, and modestly extending the survival of male mice.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These results show that PAD2 is responsible for the increased PC in ALS and PC contributes to neuroinflammation and degeneration of motor neurons and myelinated axons. The modest modulation of the disease phenotype suggests that the role of PC in ALS is complex, involving altered PC in numerous proteins and in multiple cell types. Future studies are needed to investigate how PC modulates individual protein functions in various cell types to understand the contribution of PC to ALS pathogenesis.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.05.30.729013","type":"posted-content","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:50:13Z","timestamp":1780491013000},"source":"Crossref","is-referenced-by-count":0,"title":["PAD2 knockout reduces myelin protein aggregates, modulates neuroinflammation and protects motor neurons, axons and neuromuscular junction in a SOD1-ALS mouse model"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-5946","authenticated-orcid":false,"given":"Issa O.","family":"Yusuf","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio L.A.","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Amoako","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA"},{"name":"Program in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoshang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026060510501906000_2026.05.30.729013v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2025.05.008"},{"issue":"4","key":"2026060510501906000_2026.05.30.729013v1.2","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.3892\/mmr.2017.7186","article-title":"Implications of white matter damage in amyotrophic lateral sclerosis (Review)","volume":"16","year":"2017","journal-title":"Mol Med Rep"},{"key":"2026060510501906000_2026.05.30.729013v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/nature20413"},{"issue":"10","key":"2026060510501906000_2026.05.30.729013v1.4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40263-025-01217-0","article-title":"Genetic and Mechanistic Insights Inform Amyotrophic Lateral Sclerosis Treatment and Symptomatic Management: Current and Emerging Therapeutics and Clinical Trial Design Considerations","volume":"39","year":"2025","journal-title":"CNS Drugs"},{"issue":"9","key":"2026060510501906000_2026.05.30.729013v1.5","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4103\/NRR.NRR-D-24-00661","article-title":"Disruption of neuronal actin barrier promotes the entry of disease-implicated proteins to exacerbate amyotrophic lateral sclerosis pathology","volume":"20","year":"2025","journal-title":"Neural Regen Res"},{"key":"2026060510501906000_2026.05.30.729013v1.6","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00024"},{"key":"2026060510501906000_2026.05.30.729013v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a133189"},{"key":"2026060510501906000_2026.05.30.729013v1.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0625-x"},{"issue":"4","key":"2026060510501906000_2026.05.30.729013v1.9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/jnc.12744","article-title":"Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates","volume":"130","year":"2014","journal-title":"J Neurochem"},{"key":"2026060510501906000_2026.05.30.729013v1.10","first-page":"204","article-title":"Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury","volume":"6","year":"2015","journal-title":"Front Neurol"},{"key":"2026060510501906000_2026.05.30.729013v1.11","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3349-06.2006"},{"key":"2026060510501906000_2026.05.30.729013v1.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00834.x"},{"key":"2026060510501906000_2026.05.30.729013v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.03.028"},{"key":"2026060510501906000_2026.05.30.729013v1.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-020-01221-0"},{"issue":"13","key":"2026060510501906000_2026.05.30.729013v1.15","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.7150\/ijbs.97166","article-title":"AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment-Efficacy and Mechanism","volume":"20","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2026060510501906000_2026.05.30.729013v1.16","doi-asserted-by":"crossref","first-page":"40583","DOI":"10.1038\/s41598-025-24221-2","article-title":"Peptidylarginine deiminase 2 contributes to pathogenesis in trinitrobenzenesulfonic acid-induced colitis through macrophage extracellular trap-independent pathways","volume":"15","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"2026060510501906000_2026.05.30.729013v1.17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SHK.0000000000001489","article-title":"Peptidylarginine Deiminase 2 Knockout Improves Survival in hemorrhagic shock","volume":"54","year":"2020","journal-title":"Shock"},{"key":"2026060510501906000_2026.05.30.729013v1.18","doi-asserted-by":"crossref","unstructured":"Tian Y , Qu S , Alam HB , Williams AM , Wu Z , Deng Q , et al. Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis. JCI Insight. 2020;5(20).","DOI":"10.1172\/jci.insight.138873"},{"issue":"2","key":"2026060510501906000_2026.05.30.729013v1.19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/TA.0000000000004813","article-title":"Role of peptidylarginine deiminase 2 in a murine model of traumatic brain injury","volume":"100","year":"2026","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"2026060510501906000_2026.05.30.729013v1.20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s40478-022-01433-5","article-title":"Protein citrullination marks myelin protein aggregation and disease progression in mouse ALS models","volume":"10","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"2026060510501906000_2026.05.30.729013v1.21","doi-asserted-by":"crossref","first-page":"106414","DOI":"10.1016\/j.nbd.2024.106414","article-title":"PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS","volume":"192","year":"2024","journal-title":"Neurobiol Dis"},{"key":"2026060510501906000_2026.05.30.729013v1.22","doi-asserted-by":"publisher","DOI":"10.1006\/cbir.1993.1094"},{"issue":"1","key":"2026060510501906000_2026.05.30.729013v1.23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-025-00838-9","article-title":"Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis","volume":"20","year":"2025","journal-title":"Mol Neurodegener"},{"key":"2026060510501906000_2026.05.30.729013v1.24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.1c00369"},{"issue":"4","key":"2026060510501906000_2026.05.30.729013v1.25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.33696\/Neurol.5.101","article-title":"Protein Citrullination in Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases","volume":"5","year":"2024","journal-title":"J Exp Neurol"},{"key":"2026060510501906000_2026.05.30.729013v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67165-9"},{"key":"2026060510501906000_2026.05.30.729013v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105032"},{"key":"2026060510501906000_2026.05.30.729013v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.03.053"},{"key":"2026060510501906000_2026.05.30.729013v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24183"},{"key":"2026060510501906000_2026.05.30.729013v1.30","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1217-2"},{"issue":"7","key":"2026060510501906000_2026.05.30.729013v1.31","doi-asserted-by":"crossref","first-page":"e28553","DOI":"10.1016\/j.heliyon.2024.e28553","article-title":"Serum cytokines profile changes in amyotrophic lateral sclerosis","volume":"10","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"2026060510501906000_2026.05.30.729013v1.32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","article-title":"Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes","volume":"74","year":"2017","journal-title":"JAMA Neurol"},{"key":"2026060510501906000_2026.05.30.729013v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17514-9"},{"key":"2026060510501906000_2026.05.30.729013v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab328"},{"key":"2026060510501906000_2026.05.30.729013v1.35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-133702"},{"key":"2026060510501906000_2026.05.30.729013v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.03.004"},{"issue":"1","key":"2026060510501906000_2026.05.30.729013v1.37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-025-01951-y","article-title":"Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and - independent mechanisms","volume":"13","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"2026060510501906000_2026.05.30.729013v1.38","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.8.42"},{"issue":"1","key":"2026060510501906000_2026.05.30.729013v1.39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbrc.2017.04.031","article-title":"Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis","volume":"487","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2026060510501906000_2026.05.30.729013v1.40","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04126-3"},{"key":"2026060510501906000_2026.05.30.729013v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00612-2"},{"issue":"1","key":"2026060510501906000_2026.05.30.729013v1.42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10571-024-01482-5","article-title":"Astrocyte-Specific Inhibition of the Primary Cilium Suppresses C3 Expression in Reactive Astrocyte","volume":"44","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"2026060510501906000_2026.05.30.729013v1.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013126"},{"key":"2026060510501906000_2026.05.30.729013v1.44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbi.2024.09.022","article-title":"Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson\u2019s disease","volume":"123","year":"2025","journal-title":"Brain Behav Immun"},{"key":"2026060510501906000_2026.05.30.729013v1.45","doi-asserted-by":"crossref","unstructured":"Shi Q , Chowdhury S , Ma R , Le KX , Hong S , Caldarone BJ , et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017;9(392).","DOI":"10.1126\/scitranslmed.aaf6295"},{"key":"2026060510501906000_2026.05.30.729013v1.46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318309110"},{"key":"2026060510501906000_2026.05.30.729013v1.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1321248111"},{"key":"2026060510501906000_2026.05.30.729013v1.48","doi-asserted-by":"crossref","first-page":"106161","DOI":"10.1016\/j.neuint.2026.106161","article-title":"C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications","volume":"196","year":"2026","journal-title":"Neurochem Int"},{"key":"2026060510501906000_2026.05.30.729013v1.49","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu214"},{"key":"2026060510501906000_2026.05.30.729013v1.50","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1384829"},{"key":"2026060510501906000_2026.05.30.729013v1.51","doi-asserted-by":"crossref","unstructured":"Renzini A , Pigna E , Rocchi M , Cedola A , Gigli G , Moresi V , et al. Sex and HDAC4 Differently Affect the Pathophysiology of Amyotrophic Lateral Sclerosis in SOD1-G93A Mice. Int J Mol Sci. 2022;24(1).","DOI":"10.3390\/ijms24010098"},{"key":"2026060510501906000_2026.05.30.729013v1.52","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26933"},{"issue":"2","key":"2026060510501906000_2026.05.30.729013v1.53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-140068","article-title":"Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis","volume":"2","year":"2015","journal-title":"J Neuromuscul Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.30.729013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:50:32Z","timestamp":1780681832000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.05.30.729013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":53,"URL":"https:\/\/doi.org\/10.64898\/2026.05.30.729013","relation":{},"subject":[],"published":{"date-parts":[[2026,6,3]]},"subtype":"preprint"}}